Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus

102Citations
Citations of this article
73Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A growing body of evidence has suggested that reactive oxygen species (ROS) may play an important role in the physiopathology of depression. Evidence has pointed to the β-carboline harmine as a potential therapeutic target for the treatment of depression. The present study we evaluated the effects of acute and chronic administration of harmine (5, 10 and 15 mg/kg) and imipramine (10, 20 and 30 mg/kg) or saline in lipid and protein oxidation levels and superoxide dismutase (SOD) and catalase (CAT) activities in rat prefrontal cortex and hippocampus. Acute and chronic treatments with imipramine and harmine reduced lipid and protein oxidation, compared to control group in prefrontal cortex and hippocampus. The SOD and CAT activities increased with acute and chronic treatments with imipramine and harmine, compared to control group in prefrontal cortex and hippocampus. In conclusion, our results indicate positive effects of imipramine antidepressant and β-carboline harmine of oxidative stress parameters, increasing SOD and CAT activities and decreasing lipid and protein oxidation.

Cite

CITATION STYLE

APA

Réus, G. Z., Stringari, R. B., De Souza, B., Petronilho, F., Dal-Pizzol, F., Hallak, J. E., … Quevedo, J. (2010). Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxidative Medicine and Cellular Longevity, 3(5), 325–331. https://doi.org/10.4161/oxim.3.5.13109

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free